Eliminate
Cancer
from the world

We are developing drugs for pancreatic cancer and small cell lung cancer.

News

2025.06.24

Our website has been updated, and now includes information on each of our pipelines. We encourage you to visit and explore the new content.

2025.05.28

AntiCancer Technologies Inc. has opened official social media accounts to strengthen information dissemination. We will continue to share company initiatives and announcements.
・Facebook ・ LinkedIn・ X (formerly Twitter)・Instagram

2025.04.25

We have been selected for the startup support program "NCC Seed Acceleration Program (NCC SAP)" hosted by the National Cancer Center Japan's Center for Translational Research. (For details, click here)

See More

Research Content

We are working on developing innovative treatments for highly malignant cancers (pancreatic cancer, small cell lung cancer, etc.)

Small Cell Lung Cancer Icon

Small Cell Lung Cancer

Developing small molecule compounds that inhibit metabolic enzymes highly expressed in small cell lung cancer, promoting new treatment realization.

Learn More
Pancreatic Cancer Icon

Pancreatic Cancer

Developing antibody therapy targeting signal paths specific to pancreatic cancer stem cells, aiming for clinical application.

Learn More
All Cancers Icon

All Cancers

Developing therapeutic agents targeting all solid tumors by inhibiting cancer stem cell-specific ubiquitin ligase E3.

Learn More